Skip to main content
. Author manuscript; available in PMC: 2011 Mar 22.
Published in final edited form as: J Perinatol. 2009 Jan 15;29(3):195–200. doi: 10.1038/jp.2008.222

Figure 2.

Figure 2

Digibind-attenuated tumor necrosis factor-α (TNFα)-induced ICAM, VCAM and E-selectin expressions in endothelial cells (ECs). ECs were pretreated with Digibind (50 and 100 µg ml−1) for 1 h and then TNFα at a concentration of 100 pg ml−1 for 2 h. Digibind could dose-dependently attenuate TNFα-induced upregulation of ICAM, VCAM and E-selectin expression. Data are means from six independent experiments, each in triplicate. **P<0.01: TNFα-treated only vs control; #P<0.05 and ##P<0.01: cells treated with Digibind + TNFα vs TNFα-treated only, respectively.